SCHEMBL605677

SCHEMBL605677

CC1(C)CCC1(C)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9908376 0.75
SCHEMBL9820450 0.74
SCHEMBL14175334 0.73
SCHEMBL397567 0.71
SCHEMBL397568 0.71
SCHEMBL25002994 0.67
SCHEMBL791384 0.67
SCHEMBL8736839 0.67
SCHEMBL17827263 0.67
SCHEMBL8738428 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180008523-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD DEVICEFARM INC (US) 2018-01-11 US claimed
US-20180000937-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD DEVICEFARM INC (US) 2018-01-04 US claimed
US-20170361078-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD NATIONAL SCIENCE FOUNDATION 2017-12-21 US claimed
US-20170354616-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD NATIONAL SCIENCE FOUNDATION 2017-12-14 US claimed
US-20170354815-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD NATIONAL SCIENCE FOUNDATION 2017-12-14 US claimed
EP-2044192-A2 ENHANCED OXYGEN CELL CULTURE PLATFORMS University of Miami (US) 2009-04-08 EP claimed
WO-2008006104-A2 ENHANCED OXYGEN CELL CULTURE PLATFORMS UNIVERSITY OF MIAMI (US) 2008-01-10 WO claimed
US-20080009027-A1 Enhanced Oxygen Cell Culture Platforms UNIVERSITY OF MIAMI (US) 2008-01-10 US claimed
US-7081092-B2 Methods and apparatus for monitoring and quantifying the movement of fluid IMCOR PHARMACEUTICAL COMPANY (US) 2006-07-25 US claimed
US-20050049484-A1 Methods and apparatus for monitoring and quantifying the movement of fluid TARGESON, INC. 2005-03-03 US claimed
US-6802813-B2 Methods and apparatus for monitoring and quantifying the movement of fluid IMCOR PHARMACEUTICAL CO. 2004-10-12 US claimed
US-20030220563-A1 Methods and apparatus for monitoring and quantifying the movement of fluid TARGESON, INC. 2003-11-27 US claimed
US-20020065467-A1 Methods and apparatus for monitoring and quantifying the movement of fluid SCHUTT ERNEST G (US) 2002-05-30 US claimed
WO-1998053855-A1 METHODS AND APPARATUS FOR MONITORING AND QUANTIFYING THE MOVEMENT OF FLUID ALLIANCE PHARMACEUTICAL CORP. (US) 1998-12-03 WO claimed
US-20250009652-A1 COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS PEARL THERAPEUTICS, INC. 2025-01-09 US disclosed
US-20240252439-A1 PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY DAMAGE AND USE FOR MANUFACTURING PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY DAMAGE HUNG MING CHIEN (TW) 2024-08-01 US disclosed
US-20240024229-A1 COMPOSITIONS, METHODS &amp; SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS PEARL THERAPEUTICS, INC. 2024-01-25 US disclosed
WO-1999016419-A9 PERFORATED MICROPARTICLES AND METHODS OF USE ALLIANCE PHARMA (US) 1999-08-19 WO disclosed
WO-1999016419-A1 PERFORATED MICROPARTICLES AND METHODS OF USE INHALE THERAPEUTIC SYSTEMS, INC. (US) 1999-04-08 WO disclosed
WO-1998053855-A1 METHODS AND APPARATUS FOR MONITORING AND QUANTIFYING THE MOVEMENT OF FLUID ALLIANCE PHARMACEUTICAL CORP. (US) 1998-12-03 WO disclosed